Manuscripts
Showing 1551 manuscripts.
Vitamin D-related host genetic variants alter HIV disease progression in children.
Citation
KK Singh, SA Spector, A Moodley, M Qin. Vitamin D-related host genetic variants alter HIV disease progression in children.. Pediatric Infectious Disease Journal. 2013. 32: 1230-1236. PMID: 23736144Year
2013
Journal
Pediatric Infectious Disease Journal
Immunology of pediatric HIV infection
Citation
NH Tobin, GM Aldrovandi. Immunology of pediatric HIV infection. European Journal of Immunology. 2013. 254: 143-169. PMID: 23772619Year
2013
Journal
European Journal of Immunology
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central Nervous System Impairment in Children
Citation
KP Gray, M Farhad, S Brummel, T Fenton, R Trout, SA Spector, KK Singh, Y Wang. Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central Nervous System Impairment in Children. Journal of Acquired Immune Deficiency Syndromes. 2013. 62: 197-203. PMID: 23138837Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Pubertal Onset in children with perinatal HIV-infected in the Era of Combination Antiretroviral Treatment
Citation
Denise L. Jacobson, Jiajia Wang, Russell B. Van Dyke, Rohan Hazra, Kunjal Patel, Linda A. DiMeglio, Elizabeth J. McFarland, M Silio, W Borkowsky, GR Seage 3rd, JM Oleske, ME Geffner, IMPAACT P219 & 219c, Paige L. Williams, Mark J. Abzug. Pubertal Onset in children with perinatal HIV-infected in the Era of Combination Antiretroviral Treatment. AIDS. 2013. 27: 1959-1970. PMID: 24145244Year
2013
Journal
AIDS
Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery
Citation
Deborah Kacanek, David E Shapiro, Jennifer S Read, Yvonne Bryson, Judith S Currier, Risa M Hoffman, Erin Leister. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. Journal of Acquired Immune Deficiency Syndromes. 2013. 63: 593-601. PMID: 23714738Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children
Citation
Jane C Lindsey, Carrie Fry, Matthew M Cousins, Robert F Siliciano, Avy Violari, Paul Palumbo, Susan H Eshleman, Iris Chen, Leila Khaki. Association of pol diversity with antiretroviral treatment outcomes among HIV-infected African children. PLoS One. 2013. 8: e81213. PMID: 24312277Year
2013
Journal
PLoS One
Study
P1060
Examining the challenges and solutions to the implementation of trials in resource-limited settings: limited resource trials
Citation
Christina Blanchard-Horan, Vicki Stocker, Laura E. Moran, Elaine Ferguson, Karin L. Klingman, Deborah McMahon, Jane Hitti. Examining the challenges and solutions to the implementation of trials in resource-limited settings: limited resource trials. Applied Clinical Trials. 2012. 21: 34-42. PMID: 22798719Year
2012
Journal
Applied Clinical Trials
Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures
Citation
Athe Tsibris, Kay E. Leopold, Roger Paredes, Eoin Coakley, Zhaohui Su, Wayne Greaves, Roy (Trip) Gulick, Daniel R. Kuritzkes. Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures. Journal of Virology. 2012. 86: 6416-26. PMID: 22491471Year
2012
Journal
Journal of Virology
Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy
Citation
Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Medicine. 2012. 13: 372-8. PMID: 22257000Year
2012
Journal
HIV Medicine
Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)
Citation
Robert J. McLinden. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170). AIDS. 2012. 26: 1-9. PMID: 21971356Year
2012
Journal
AIDS